S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新: Immunome, Inc. [IMNM]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
BUY
66.67%
return 0.92%
SELL
50.00%
return -1.61%
最后更新时间27 Apr 2024 @ 04:00

-3.72% $ 13.73

购买 104722 min ago

@ $22.58

发出时间: 15 Feb 2024 @ 03:40


回报率: -39.18%


上一信号: Feb 14 - 23:32


上一信号: 出售


回报率: 6.29 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):
Profile picture for Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system...

Stats
今日成交量 967 464
平均成交量 803 233
市值 586.68M
EPS $0 ( 2024-03-21 )
下一个收益日期 ( $0 ) 2024-05-03
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -7.63
ATR14 $0.0190 (0.14%)
Insider Trading
Date Person Action Amount type
2024-02-20 Horn Kinney Buy 300 000 Stock option (right to buy)
2024-02-12 Horn Kinney Buy 0
2024-01-31 Rosett Max Buy 175 000 Stock option (right to buy)
2024-01-31 Stoneman Sandra G. Buy 200 000 Stock option (right to buy)
2024-01-02 Lapetina Bob Sell 0 Common Stock
INSIDER POWER
-15.83
Last 93 transactions
Buy: 3 618 517 | Sell: 4 251 388

音量 相关性

長: -0.33 (neutral)
短: -0.83 (strong negative)
Signal:(33.86) Neutral

Immunome, Inc. 相关性

10 最正相关
TNXP0.823
MBIO0.812
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Immunome, Inc. 相关性 - 货币/商品

The country flag 0.16
( neutral )
The country flag 0.33
( neutral )
The country flag 0.00
( neutral )
The country flag 0.23
( neutral )
The country flag -0.46
( neutral )
The country flag -0.15
( neutral )

Immunome, Inc. 财务报表

Annual 2022
营收: $0
毛利润: $-631 000 (0.00 %)
EPS: $-3.09
FY 2022
营收: $0
毛利润: $-631 000 (0.00 %)
EPS: $-3.09
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-5.63
FY 2020
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-5.26

Financial Reports:

No articles found.

Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。